Specifically, glutamine substitutions at position 71 of VIM and position 988 of CILP were predicted to improve affinity for HLA‐DR RA susceptibility alleles compared to the native peptides, confirming that glutamine affects MHC‐II binding in a similar manner to citrulline. This evidence concerns the gene CILP and rheumatoid arthritis.